-
The Role of GLP-1 Based Therapies in Liver Fibrosis and MASH
The Role of GLP-1 Based Therapies in Liver Fibrosis and MASH
Join us on Thursday, 5 December 2024 from 7:00 pm to 8:00 pm (AEDT) as we discuss the latest trials on the management of MASH in people with and without diabetes. We’ll focus on the Australian clinical context, considering GESA’s recent position statement on MAFLD screening and diagnosis as well as ADS’ provision statement on managing […]